Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2025
Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective Study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Argentino Gennaro, Paribello Giuseppe, Foderini Andrea, Marzano Federica, Amicone Maria, Riccio Eleonora, Pisani Antonio, Andriella Simona, Ruotolo Chiara, Ambrosino Tino Paolo, Cascone Francesco, Di Martino Luigi, Camocardi Andrea, Genualdo Raffaele, Romano Francesco Maria, Selvaggi Lucio, Selvaggi Francesco, Dallio Marcello, Federico Alessandro, De Nicola Luca, Garofalo Carlo, Borrelli Silvio
Аннотация
OBJECTIVE: Chronic constipation is prevalent in patients undergoing peritoneal dialysis (PD), raising the risk of catheter malfunction and transmural peritonitis. Gut dysbiosis in dialysis patients can worsen constipation.
METHODS: A single-arm prospective study was performed to assess the effectiveness of synbiotic (fructo-oligosaccharides and Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus reuteri, and Saccharomyces boulardii) supplementation for 16 weeks in PD patients suffering from chronic constipation. The endpoints were the changes in the constipation scoring system and in laxative use.
RESULTS: Out of 106 patients, 76 patients experienced chronic constipation and 70 completed the study. After 16 weeks of synbiotic supplementation, a significant improvement in constipation score was found (-5.3; 95% CI: -5.9/-4.7; P = .001) associated with suspension (36.8%) or reduction (42.1%) of laxatives among baseline users (57/70). The findings were not influenced by age, sex, diabetes, obesity, type of PD, residual diuresis, multidrug therapy, and severe constipation at baseline.
CONCLUSIONS: Synbiotic supplementation is associated with constipation relief and reduction in laxatives use.
METHODS: A single-arm prospective study was performed to assess the effectiveness of synbiotic (fructo-oligosaccharides and Lactobacillus casei, Lactobacillus rhamnosus, Lactobacillus reuteri, and Saccharomyces boulardii) supplementation for 16 weeks in PD patients suffering from chronic constipation. The endpoints were the changes in the constipation scoring system and in laxative use.
RESULTS: Out of 106 patients, 76 patients experienced chronic constipation and 70 completed the study. After 16 weeks of synbiotic supplementation, a significant improvement in constipation score was found (-5.3; 95% CI: -5.9/-4.7; P = .001) associated with suspension (36.8%) or reduction (42.1%) of laxatives among baseline users (57/70). The findings were not influenced by age, sex, diabetes, obesity, type of PD, residual diuresis, multidrug therapy, and severe constipation at baseline.
CONCLUSIONS: Synbiotic supplementation is associated with constipation relief and reduction in laxatives use.